Checkmate Pharmaceuticals

$11.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+0.60%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CMPI and other stocks, options, and ETFs commission-free!

About CMPI

Checkmate Pharmaceuticals, Inc. Common Stock, also called Checkmate Pharmaceuticals, is a clinical-stage biotechnology company. Read More It engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. It specializes in the field of CpG oligonucleotides. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. The listed name for CMPI is Checkmate Pharmaceuticals, Inc. Common Stock.

Employees
22
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
252.96M
Price-Earnings Ratio
Dividend Yield
Average Volume
20.21K
High Today
$11.98
Low Today
$11.73
Open Price
$11.74
Volume
11.92K
52 Week High
$16.49
52 Week Low
$8.61

Collections

CMPI Earnings

-$7.37
-$4.91
-$2.46
-$0.00
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 16, Pre-Market

You May Also Like